285 related articles for article (PubMed ID: 30242861)
21. [The effect of the activation of cannabinoid receptor on the proliferation and apoptosis of hepatoma HepG2 cells].
Wang Y; Zhou YT; Zhao Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Apr; 26(4):344-7. PubMed ID: 20368112
[TBL] [Abstract][Full Text] [Related]
22. The cannabinoid receptor agonist WIN 55,212-2 inhibits antigen-induced plasma extravasation in guinea pig airways.
Fukuda H; Abe T; Yoshihara S
Int Arch Allergy Immunol; 2010; 152(3):295-300. PubMed ID: 20150748
[TBL] [Abstract][Full Text] [Related]
23. Treatment with Cannabinoids as a Promising Approach for Impairing Fibroblast Activation and Prostate Cancer Progression.
Pietrovito L; Iozzo M; Bacci M; Giannoni E; Chiarugi P
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991773
[TBL] [Abstract][Full Text] [Related]
24. Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development.
Shoeib AM; Yarbrough AL; Ford BM; Franks LN; Urbaniak A; Hensley LL; Benson LN; Mu S; Radominska-Pandya A; Prather PL
Life Sci; 2021 Nov; 285():119993. PubMed ID: 34592231
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2.
Olea-Herrero N; Vara D; Malagarie-Cazenave S; Díaz-Laviada I
Br J Cancer; 2009 Sep; 101(6):940-50. PubMed ID: 19690545
[TBL] [Abstract][Full Text] [Related]
26. Platycodin D induces tumor growth arrest by activating FOXO3a expression in prostate cancer in vitro and in vivo.
Zhou R; Lu Z; Liu K; Guo J; Liu J; Zhou Y; Yang J; Mi M; Xu H
Curr Cancer Drug Targets; 2015; 14(9):860-71. PubMed ID: 25431082
[TBL] [Abstract][Full Text] [Related]
27. Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma.
Giuliano M; Pellerito O; Portanova P; Calvaruso G; Santulli A; De Blasio A; Vento R; Tesoriere G
Biochimie; 2009 Apr; 91(4):457-65. PubMed ID: 19059457
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2.
Scholl A; Ivanov I; Hinz B
Oncotarget; 2016 Sep; 7(38):61438-61457. PubMed ID: 27556861
[TBL] [Abstract][Full Text] [Related]
29. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
Mulè F; Amato A; Baldassano S; Serio R
Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
[TBL] [Abstract][Full Text] [Related]
30. The cannabinoid agonist WIN 55,212-2 inhibits TNF-alpha-induced neutrophil transmigration across ECV304 cells.
Nilsson O; Fowler CJ; Jacobsson SO
Eur J Pharmacol; 2006 Oct; 547(1-3):165-73. PubMed ID: 16928371
[TBL] [Abstract][Full Text] [Related]
31. Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury.
Johanek LM; Simone DA
Pain; 2004 Jun; 109(3):432-442. PubMed ID: 15157704
[TBL] [Abstract][Full Text] [Related]
32. Cannabinoid/agonist WIN 55,212-2 reduces cardiac ischaemia–reperfusion injury in Zucker diabetic fatty rats: role of CB2 receptors and iNOS/eNOS.
González C; Herradón E; Abalo R; Vera G; Pérez-Nievas BG; Leza JC; Martín MI; López-Miranda V
Diabetes Metab Res Rev; 2011 May; 27(4):331-40. PubMed ID: 21309057
[TBL] [Abstract][Full Text] [Related]
33. The antimitogenic effect of the cannabinoid receptor agonist WIN55212-2 on human melanoma cells is mediated by the membrane lipid raft.
Scuderi MR; Cantarella G; Scollo M; Lempereur L; Palumbo M; Saccani-Jotti G; Bernardini R
Cancer Lett; 2011 Nov; 310(2):240-9. PubMed ID: 21807457
[TBL] [Abstract][Full Text] [Related]
34. Cannabinoid WIN 55,212-2 Inhibits Human Glioma Cell Growth by Triggering ROS-Mediated Signal Pathways.
Wang K; Wang Q; Li Q; Zhang Z; Gao J; Fan C; Sun B; Ni Q
Biomed Res Int; 2021; 2021():6612592. PubMed ID: 33977107
[TBL] [Abstract][Full Text] [Related]
35. Cholestane-3β, 5α, 6β-triol suppresses proliferation, migration, and invasion of human prostate cancer cells.
Lin CY; Huo C; Kuo LK; Hiipakka RA; Jones RB; Lin HP; Hung Y; Su LC; Tseng JC; Kuo YY; Wang YL; Fukui Y; Kao YH; Kokontis JM; Yeh CC; Chen L; Yang SD; Fu HH; Chen YW; Tsai KK; Chang JY; Chuu CP
PLoS One; 2013; 8(6):e65734. PubMed ID: 23785446
[TBL] [Abstract][Full Text] [Related]
36. WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway.
Fakhfouri G; Ahmadiani A; Rahimian R; Grolla AA; Moradi F; Haeri A
Neuropharmacology; 2012 Sep; 63(4):653-66. PubMed ID: 22634229
[TBL] [Abstract][Full Text] [Related]
37. A combination of desmopressin and docetaxel inhibit cell proliferation and invasion mediated by urokinase-type plasminogen activator (uPA) in human prostate cancer cells.
Sasaki H; Klotz LH; Sugar LM; Kiss A; Venkateswaran V
Biochem Biophys Res Commun; 2015 Aug; 464(3):848-54. PubMed ID: 26182875
[TBL] [Abstract][Full Text] [Related]
38. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
[TBL] [Abstract][Full Text] [Related]
39. The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms.
Potenzieri C; Harding-Rose C; Simone DA
Brain Res; 2008 Jun; 1215():69-75. PubMed ID: 18486111
[TBL] [Abstract][Full Text] [Related]
40. Eupatilin Inhibits the Proliferation and Migration of Prostate Cancer Cells through Modulation of PTEN and NF-κB Signaling.
Serttas R; Koroglu C; Erdogan S
Anticancer Agents Med Chem; 2021; 21(3):372-382. PubMed ID: 32781972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
